Tutor Perini and V2X shares rise on S&P SmallCap 600 inclusion By Investing.com
Investing.com reports Tutor Perini (NYSE:TPC) rose 7.4% after hours and V2X (NYSE:VVX) gained 3.9% after S&P Dow Jones Indices said both will be added to the S&P SmallCap 600. TPC replaces Krystal Biotech (NASDAQ:KRYS) effective July 24. VVX joins July 27 replacing Avanos Medical (NYSE:AVNS), which is being acquired by American Industrial Partners.
How this was made
The 30-second read
Why it matters
The newest actionable fact is the announced inclusion timing for TPC and VVX, which can drive passive buying and short-term momentum.
Market read
Traders can front-run or hedge around passive rebalancing dates for TPC and VVX.
What to watch
The article does not quantify expected index-fund flow size, and other concurrent earnings-week moves could dominate follow-through.
Background
S&P Dow Jones Indices rebalances the S&P SmallCap 600, promoting/demoting constituents across SmallCap and MidCap benchmarks.
Ticker impact
Tutor Perini shares rose after-hours as S&P Dow Jones Indices announced it will join the S&P SmallCap 600 on July 24.
Near-term upward bias into the effective date, with potential mean reversion after rebalancing.
The article cites a specific benchmark change with an effective date, a common driver of short-term flows.
V2X gained after-hours after the S&P SmallCap 600 inclusion announcement, effective July 27.
Support for the stock into late July, followed by normalization post-rebalance.
The catalyst is concrete (index addition plus date), but magnitude is not quantified in the text.
Market effects
Small-cap index reconstitution can shift relative performance within industrials and defense-adjacent names.
Primarily US passive-flow impact via S&P benchmark tracking.
Limited, mostly affects US small-cap allocation and ETF/benchmark flows.
Counterpoint
Index-inclusion pops can fade quickly if the market already priced the change or if liquidity/positioning is crowded.
Key entities
- companyTutor Perini Corporation
Announced to replace Krystal Biotech in the S&P SmallCap 600 effective prior to July 24 open.
- companyV2X Inc.
Announced to join the S&P SmallCap 600 on July 27, replacing Avanos Medical.
- companyKrystal Biotech Inc.
Promoted to the S&P MidCap 400, creating the SmallCap vacancy for TPC.
- companyAvanos Medical Inc.
Replaced in the SmallCap 600 as American Industrial Partners acquisition is expected to close soon.


